These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17018759)

  • 61. Antiemesis clinical practice guidelines in oncology.
    Ettinger DS; Bierman PJ; Bradbury B; Ellis G; Ignoffo RJ; Kirkegaard S; Kloth D; Krauss A; Kris MG; Lim D; Markiewicz MA; McNulty R; Noonan K; Stucky-Marshall L; Todaro B; Urba S; Yowell S;
    J Natl Compr Canc Netw; 2004 Sep; 2(5):470-90. PubMed ID: 19780255
    [No Abstract]   [Full Text] [Related]  

  • 62. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J
    Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NCCN antiemesis practice guidelines.
    Oncology (Williston Park); 1997 Nov; 11(11A):57-89. PubMed ID: 9430179
    [No Abstract]   [Full Text] [Related]  

  • 64. Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists.
    Schwartz RH; Beveridge RA
    J Addict Dis; 1994; 13(1):53-65. PubMed ID: 7503819
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
    Levitt M
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556
    [No Abstract]   [Full Text] [Related]  

  • 66. History of the development of antiemetic guidelines at Mayo Clinic Rochester.
    Loprinzi CL; Alberts SR; Christensen BJ; Hanson LJ; Farley DR; Broers JK; Betcher DL; Grady RE; Southorn PA; Johnson TM; Perez EA
    Mayo Clin Proc; 2000 Mar; 75(3):303-9. PubMed ID: 10725961
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
    Wickham R
    Cancer Control; 2012 Apr; 19(2 Suppl):3-9. PubMed ID: 22488022
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J; Szántó J
    Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The control of chemotherapy-induced nausea and vomiting].
    Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
    Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [ESMO 2004. Nausea and vomiting caused by chemotherapy: improving the treatment].
    Longo F; Mansueto G
    Tumori; 2005; 91(1):suppl 36-48. PubMed ID: 15850022
    [No Abstract]   [Full Text] [Related]  

  • 71. Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines.
    Tageja N; Groninger H
    Postgrad Med J; 2016 Jan; 92(1083):34-40. PubMed ID: 26561590
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Update on the management of chemotherapy-induced nausea and vomiting.
    Viale PH
    J Infus Nurs; 2006; 29(5):283-92. PubMed ID: 17035890
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The management of chemotherapy-induced nausea and vomiting.
    Gralla RJ; Tyson LB; Kris MG; Clark RA
    Med Clin North Am; 1987 Mar; 71(2):289-301. PubMed ID: 3546981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
    Todaro B
    J Natl Compr Canc Netw; 2012 Apr; 10(4):487-92. PubMed ID: 22491047
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Nausea and vomiting induced by antineoplastic therapy].
    Petersen PC; Ruhlmann C; Herrstedt J
    Ugeskr Laeger; 2019 Jul; 181(27):. PubMed ID: 31267940
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improving Adherence to Evidence-Based Guidelines for Chemotherapy-Induced Nausea and Vomiting.
    Wood M; Hall L; Hockenberry M; Borinstein S
    J Pediatr Oncol Nurs; 2015; 32(4):195-200. PubMed ID: 25576315
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting.
    Spitzer TR; Grunberg SM; Dicato MA
    Support Care Cancer; 1998 May; 6(3):233-6. PubMed ID: 9629875
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Antiemetic and antinauseant effect of alizapride in patients subjected to antiblastic infusion chemotherapy in a day-hospital regime].
    Cicchetti F; Viganò P; Borghi CM; Franzini A; Alfano G; Antolini C
    G Ital Oncol; 1989; 9(1):18-21. PubMed ID: 2707835
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The efficacy and cost effectiveness of new antiemetic guidelines.
    Engstrom C; Hernandez I; Haywood J; Lilenbaum R
    Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Managing chemotherapy-related nausea and vomiting: the state of the art.
    Wickham R
    Oncol Nurs Forum; 1989; 16(4):563-74. PubMed ID: 2666957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.